Insights

He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD.

He discusses how gastroenterologists can resume semi-elective and elective endoscopies by following key guidelines to protect patients and staff against COVID-19.

He talks about his latest research paper in which his team used machine learning to develop a risk-stratification model to predict which patients would experience upper gastrointestinal bleeding and then compared the model’s performance with...

The relationship between climate change and human health has not been thoroughly explored. Desmond Leddin, MB, MSc, has taken an interest in studying this relationship. In this Q&A, he answers our questions about his latest article on the...

In this video, Gastroenterology Consultant Advisory Board Member David Hudesman, MD, talks about how his staff is coping with COVID-19 challenges, as well as how he helps his staff reduce stress and risk of infection.

He talks about the American College of Gastroenterology's new clinical guideline on small intestinal bacterial overgrowth (SIBO), how the guideline attempts to clear up the controversies around diagnosis and treatment of SIBO, and more.

She talks about the latest NASPGHAN position paper on roles of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the evaluation and treatment of chronic pancreatitis in children.